Greg Pyszczymuka
Fortune : 77 619 $ au 30/06/2026
Fortune : 77 619 $ au 30/06/2026
Greg Pyszczymuka is currently Chief Commercial Officer at Aytu Biopharma, Inc. since 2022.
Former positions include Independent Director at Evoke Pharma, Inc. in 2025 and Vice President-Commercial at Neos Therapeutics, Inc. from 2020 to 2021.
Education includes an MBA from Argosy University and an undergraduate degree from Rutgers State University of New Jersey.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
AYTU BIOPHARMA, INC. 0,34 % | 13/10/2025 | 36 102 ( 0,34 % ) | 77 619 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| AYTU BIOPHARMA, INC. | Corporate Officer/Principal | 01/01/2022 |
| Sociétés | Poste | Fin |
|---|---|---|
| EVOKE PHARMA, INC. | Directeur/Membre du Conseil | 17/12/2025 |
| NEOS THERAPEUTICS, INC. | Corporate Officer/Principal | 31/03/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 5 |
|---|---|
Evoke Pharma, Inc.
Evoke Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets drugs to treat gastrointestinal | Health Technology |
Argosy University
Argosy University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Neos Therapeutics, Inc.
Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets central nervous system-focused products | Health Technology |
Aytu Biopharma, Inc.
Aytu Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national